A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.

AUTOR(ES)

Milligan, N M

RESUMO

Isoprinosine was used under double-blind, randomised, and placebo-controlled conditions in 52 patients with relapsing/remitting or progressive multiple sclerosis. All patients received pulsed treatment with methylprednisolone. There was no significant effect of treatment on clinical disability or the accumulation of MRI abnormalities, after correction of results for multiple comparisons. It is concluded that isoprinosine is not effective therapy for multiple sclerosis.

Documentos Relacionados

• Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.
• Non-specific urethritis. A placebo-controlled trial of minocycline in conjunction with laboratory investigations.
• Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial
• Placebo-controlled trial of quinine therapy for nocturnal leg cramps.
• Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis